WASHINGTON, June 29 (UPI) -- The U.S. National Institute of Allergy and Infectious Diseases announced Thursday the new structure of its HIV/AIDS clinical trials networks.
The NIAID, part of the National Institutes of Health, said the networks will search for safe and effective treatments and prevention strategies, including HIV vaccines.
"The new network structure expands our clinical research capacity and strengthens our ability to take advantage of emerging scientific opportunities," said NIAID Director Dr. Anthony Fauci. "By creating a more integrated, collaborative and flexible structure, we will be better equipped to meet evolving global AIDS research priorities."
The principal investigators and institutions leading the newly restructured HIV/AIDS networks are:
-- AIDS Clinical Trials Group -- Dr. Constance Benson of the University of California-San Diego.
-- HIV Prevention Trials Network -- Dr. Sten Vermund of Vanderbilt University.
-- HIV Vaccine Trials Network -- Dr. Lawrence Corey of The Fred Hutchinson Cancer Research Center.
-- International Network for Strategic Initiatives in Global HIV Trials -- James Neaton of the University of Minnesota.
-- Microbicide Trials Network -- Sharon Hillier of the Magee-Women's Research Institute.